logo-loader
viewArcadia Biosciences Inc

Full interview: Arcadia Biosciences records some big wins in the 3rd Quarter

Arcadia Biosciences (NASDAQ: RKDA) CEP Matt Plavan joined Proactive’s Steve Darling to discuss the company’s third-quarter results. Plavan also discussed some of the company highlights during that quarter including the latest on their research facilities.

Plavan also discussed their hemp operation and the expansion they had in three states.

Quick facts: Arcadia Biosciences Inc

Price: 3.72 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $39.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Animoca Brands' Yat Siu talks significant expansion of partnership with Atari

Animoca Brands Corporation Ltd's co-founder and chairman Yat Siu speaks to Proactive about an expansion to its existing license deal with classic gaming company Atari. The move gives Animoca access to an additional 15 Atari games through to 2035 as well as the right to develop and publish...

10 hours, 11 minutes ago

2 min read